1. Primary cutaneous follicle center lymphoma with extensive plasmacytic differentiation and t(14;18) in both the lymphoid and plasma cell components.
- Author
-
Kelley JT, Brown NA, Hristov AC, and Bresler SC
- Subjects
- Aged, Biopsy, Needle methods, Cell Differentiation, Diagnosis, Differential, Female, Humans, Immunoglobulin lambda-Chains metabolism, Immunohistochemistry methods, Immunophenotyping methods, In Situ Hybridization, Fluorescence methods, Lymphocytes metabolism, Lymphoma, B-Cell, Marginal Zone pathology, Lymphoma, Follicular metabolism, Neprilysin metabolism, Plasma Cells metabolism, Proto-Oncogene Proteins c-bcl-2 metabolism, Proto-Oncogene Proteins c-bcl-6 metabolism, Translocation, Genetic, Lymphocytes pathology, Lymphoma, B-Cell, Marginal Zone diagnosis, Lymphoma, Follicular diagnosis, Plasma Cells pathology, Skin Neoplasms pathology
- Abstract
Primary cutaneous follicle center lymphoma (PCFCL) is the most common cutaneous B-cell lymphoma. The typical immunophenotype includes expression of both CD20 and BCL6, with the majority of cases lacking expression of CD10, BCL2, and the characteristic t(14;18)/IGH-BCL2 rearrangement seen in systemic follicular lymphoma (FL). Plasmacytic differentiation (PD) is an uncommon finding in both systemic and cutaneous FLs and presents a diagnostic challenge when present, leading to the potential for misdiagnosis as marginal zone lymphoma (MZL). Limited reports have described light chain restriction in the plasma cell component of FLs with PD, and rare cases of PCFCL with PD have been described. While the IGH-BCL2 translocation has been identified in a subset of FLs with PD, the presence of the BCL2 translocation in monotypic plasma cells of PCFCL has not been previously described to our knowledge. Here, we report a case of PCFCL with extensive PD in a 77-year-old woman that was favored to represent primary cutaneous MZL on an initial punch biopsy. Excisional biopsy, however, revealed that the atypical lymphocytes expressed CD10, BCL6, and BCL2, while the plasma cell component demonstrated light-chain lambda restriction. FISH studies showed the presence of an IGH-BCL2 translocation in both the lymphocytic and plasmacytic components., (© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF